These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28850875)

  • 1. Intestinal patch systems for oral drug delivery.
    Banerjee A; Mitragotri S
    Curr Opin Pharmacol; 2017 Oct; 36():58-65. PubMed ID: 28850875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal patch systems for oral drug delivery.
    Tao SL; Desai TA
    Drug Discov Today; 2005 Jul; 10(13):909-15. PubMed ID: 15993810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery.
    Toorisaka E; Watanabe K; Ono H; Hirata M; Kamiya N; Goto M
    Acta Biomater; 2012 Feb; 8(2):653-8. PubMed ID: 21982846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery.
    Whitehead K; Shen Z; Mitragotri S
    J Control Release; 2004 Jul; 98(1):37-45. PubMed ID: 15245887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
    Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of Exenatide and Insulin Using Mucoadhesive Intestinal Devices.
    Gupta V; Hwang BH; Doshi N; Banerjee A; Anselmo AC; Mitragotri S
    Ann Biomed Eng; 2016 Jun; 44(6):1993-2007. PubMed ID: 26864536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration and surface of absorption: concepts and applications to gastrointestinal patches delivery.
    Teutonico D; Montanari S; Ponchel G
    Int J Pharm; 2011 Jul; 413(1-2):87-92. PubMed ID: 21536118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal patches for oral drug delivery.
    Shen Z; Mitragotri S
    Pharm Res; 2002 Apr; 19(4):391-5. PubMed ID: 12033369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfabricated devices for oral drug delivery.
    Nielsen LH; Keller SS; Boisen A
    Lab Chip; 2018 Aug; 18(16):2348-2358. PubMed ID: 29975383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ forming parenteral drug delivery systems: an overview.
    Packhaeuser CB; Schnieders J; Oster CG; Kissel T
    Eur J Pharm Biopharm; 2004 Sep; 58(2):445-55. PubMed ID: 15296966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Zonula occludens toxin: an innovative method of oral drugs delivery].
    Di Pierro M; Fasano A
    Minerva Pediatr; 2001 Feb; 53(1):15-22. PubMed ID: 11309538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable implants for the sustained release of protein and peptide drugs.
    Agarwal P; Rupenthal ID
    Drug Discov Today; 2013 Apr; 18(7-8):337-49. PubMed ID: 23410799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of low molecular weight protamine to enhance oral absorption of exenatide.
    Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y
    Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral insulin-delivery system for diabetes mellitus.
    Kanzarkar M; Pathak PP; Vaidya M; Brumlik C; Choudhury A
    Pharm Pat Anal; 2015 Jan; 4(1):29-36. PubMed ID: 25565158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
    Carrière F
    Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of proteins by biodegradable nanoparticles.
    Bakhru SH; Furtado S; Morello AP; Mathiowitz E
    Adv Drug Deliv Rev; 2013 Jun; 65(6):811-21. PubMed ID: 23608641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.